In the INA, oncology of the Tomsk NIMC reported the completion of pre-clinological testing of a new platet radiopharmaceut for diagnosis and treatment of aggressive breast cancer. The INA oncology specialists of the Tomsk NIMC, in cooperation with other scientific organizations, have developed a means for direct delivery of radioactive isotopes to cancer cells, wrote RIA News. "The docline is complete. The drug is patented, the patent belongs to…
In the INA, oncology of the Tomsk NIMC reported the completion of pre-clinological testing of a new platet radiopharmaceut for diagnosis and treatment of aggressive breast cancer. The INA oncology specialists of the Tomsk NIMC, in cooperation with other scientific organizations, have developed a means for direct delivery of radioactive isotopes to cancer cells, wrote RIA News. "The docline is complete. The drug is patented, the patent belongs to…